Several therapeutic candidates have shown promise in recent years:
1. CAR-T Cell Therapy: This innovative treatment modifies a patient's T-cells to better recognize and attack cancer cells. 2. PARP Inhibitors: These are particularly effective in cancers with specific genetic mutations, such as BRCA1 and BRCA2. 3. PD-1/PD-L1 Inhibitors: These checkpoint inhibitors have shown effectiveness in treating various cancers, including melanoma and non-small cell lung cancer. 4. Oncolytic Viruses: These are engineered viruses that selectively infect and kill cancer cells while stimulating an immune response against the tumor.
